Doctor profile · Federal record
Dr. FERNADO CABANILLAS, MD
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · SAN JUAN, PR
- NPI 1811052707
- Accepts Medicare
- MIPS 62.1 / 100 · 2023
- 56 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
725 PONCE DE LEON, PARADA 37
SAN JUAN, PR 00918
(787) 771-7933
fax (787) 294-0535 - Mailing address
-
PO BOX 362712
SAN JUAN, PR 009362712
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1970 — 56 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Puerto Rico #4069
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1811052707. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
215
Distinct HCPCS
4
Medicare allowed
$13,879
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 109 | 54 | $14 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 74 | 55 | $97 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 17 | 14 | $143 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 15 | 15 | $181 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 88. This provider delivers 2.4× the peer median.Open Payments
Industry payments received
All-time total
$1,373
Transactions
57
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $209.78 | |
| Tempus AI, Inc | 8 | $200.92 | |
| ABBVIE INC. | 8 | $172.90 | |
| PBG PUERTO RICO LLC | 6 | $128.77 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $105.69 | |
| ADC Therapeutics America, Inc. | 1 | $94.04 | |
| TAIHO ONCOLOGY, INC. | 4 | $86.78 | |
| BeiGene USA, Inc. | 3 | $72.01 | |
| Genentech USA, Inc. | 2 | $41.34 | |
| Astellas Pharma US Inc | 2 | $40.83 | |
| Janssen Pharmaceuticals, Inc | 2 | $38.77 | |
| SpringWorks Therapeutics, Inc. | 2 | $34.08 | |
| Genmab U.S., Inc. | 1 | $26.04 | |
| GENZYME CORPORATION | 1 | $26.00 | |
| PFIZER INC. | 2 | $25.85 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
205
Patients
28
Total drug cost
$732,800
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ondansetron Hcl | Generic | 34 | 17 | $230 |
| Prednisone | Generic | 31 | 0 | $143 |
| Anastrozole | Generic | 26 | 0 | $840 |
| Revlimid (Lenalidomide) | Brand | 24 | 0 | $422,318 |
| Dexamethasone | Generic | 22 | 0 | $490 |
| Calquence (Acalabrutinib Maleate) | Brand | 18 | 0 | $268,397 |
| Gabapentin | Generic | 14 | 0 | $191 |
| Bexarotene | Generic | 13 | 0 | $39,879 |
| Acyclovir | Generic | 12 | 0 | $219 |
| Paxlovid (Eua) (Nirmatrelvir/Ritonavir) | Brand | 11 | 11 | $93 |